{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:06:33Z","timestamp":1791633993628,"version":"4.3.4"},"reference-count":119,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015521","name":"Stanford Maternal and Child Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI183953"],"award-info":[{"award-number":["U01 AI183953"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL171102"],"award-info":[{"award-number":["R01 HL171102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL150693"],"award-info":[{"award-number":["R01 HL150693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL145676"],"award-info":[{"award-number":["R01 HL145676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL176822"],"award-info":[{"award-number":["R01 HL176822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25POST1372048"],"award-info":[{"award-number":["25POST1372048"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24POST1191267"],"award-info":[{"award-number":["24POST1191267"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tips.2025.07.016","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:06:24Z","timestamp":1756325184000},"page":"1072-1090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cardiac fibrosis: from mechanisms and models to medicines"],"prefix":"10.1016","volume":"46","author":[{"given":"Wenqiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.07.016_bb0005","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.123.067097","article-title":"Advanced cardiac patches for the treatment of myocardial infarction","volume":"149","author":"Liu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tips.2025.07.016_bb0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/cvr\/cvad005","article-title":"Dietary essential amino acids for the treatment of heart failure with reduced ejection fraction","volume":"119","author":"Ragni","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0020","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/CIRCULATIONAHA.122.063777","article-title":"Reduced ejection fraction in elite endurance athletes: clinical and genetic overlap with dilated cardiomyopathy","volume":"149","author":"Claessen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0025","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2025.07.016_bb0030","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","article-title":"Restrictive cardiomyopathy: definition and diagnosis","volume":"43","author":"Rapezzi","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0035","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/eurheartj\/ehad396","article-title":"Histological validation of atrial structural remodelling in patients with atrial fibrillation","volume":"44","author":"Takahashi","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020358","article-title":"Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis","volume":"10","author":"Pucci","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.tips.2025.07.016_bb0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacbts.2021.11.004","article-title":"Cardiovascular disease in Duchenne muscular dystrophy: overview and insight into novel therapeutic targets","volume":"7","author":"Schultz","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.tips.2025.07.016_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.008919","article-title":"Young Becker muscular dystrophy patients demonstrate fibrosis associated with abnormal left ventricular ejection fraction on cardiac magnetic resonance imaging","volume":"12","author":"Johnston","year":"2019","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.tips.2025.07.016_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1493570","article-title":"Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy","volume":"15","author":"Abati","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tips.2025.07.016_bb0060","article-title":"Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: an update","volume":"58","author":"Mavrogeni","year":"2023","journal-title":"Semin. Athritis Rheum."},{"key":"10.1016\/j.tips.2025.07.016_bb0065","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.123.065603","article-title":"USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart","volume":"149","author":"Xie","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/cvr\/cvaf022","article-title":"TAOK1 suppression improves doxorubicin-induced cardiomyopathy by preventing cardiomyocyte death and dysfunction","volume":"121","author":"Suga","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0075","article-title":"Prognostic significance of myocardial fibrosis in men with alcoholic cardiomyopathy: insights from cardiac MRI","author":"Li","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-024-06703-9","article-title":"Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids","volume":"15","author":"Song","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2025.07.016_bb0090","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","article-title":"Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.07.016_bb0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ame2.12124","article-title":"Establishment of adult right ventricle failure in ovine using a graded, animal-specific pulmonary artery constriction model","volume":"3","author":"Nguyen-Truong","year":"2020","journal-title":"Anim. Model Exp. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0100","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41569-022-00799-2","article-title":"Cardiac fibroblasts and mechanosensation in heart development, health and disease","volume":"20","author":"Pesce","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s44161-022-00043-7","article-title":"Fibroblasts orchestrate cellular crosstalk in the heart through the ECM","volume":"1","author":"Bowers","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0115","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.cell.2024.06.028","article-title":"Innate immune memory after brain injury drives inflammatory cardiac dysfunction","volume":"187","author":"Simats","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.07.016_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","article-title":"Targeting immune\u2013fibroblast cell communication in heart failure","volume":"635","author":"Amrute","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.016_bb0125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-024-08085-6","article-title":"Chromatin remodelling drives immune cell\u2013fibroblast communication in heart failure","volume":"635","author":"Alexanian","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.016_bb0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.121.055888","article-title":"CCL17 aggravates myocardial injury by suppressing recruitment of regulatory T cells","volume":"145","author":"Feng","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0135","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jacc.2023.10.016","article-title":"Association of lipoprotein(a) levels with myocardial fibrosis in the multi-ethnic study of atherosclerosis","volume":"82","author":"Chehab","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0140","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.abn0910","article-title":"Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure","volume":"377","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.016_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000941","article-title":"YAP\/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction","volume":"18","author":"Mia","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2025.07.016_bb0150","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/cvr\/cvab205","article-title":"Loss of Yap\/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function","volume":"118","author":"Mia","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tcb.2021.10.002","article-title":"Mechanical communication in fibrosis progression","volume":"32","author":"Long","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tips.2025.07.016_bb0160","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.actbio.2022.08.063","article-title":"Mechanosensor YAP cooperates with TGF-beta1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis","volume":"152","author":"Ragazzini","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.tips.2025.07.016_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/CIRCRESAHA.121.319373","article-title":"Reduction of cardiac fibrosis by interference with YAP-dependent transactivation","volume":"131","author":"Garoffolo","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0170","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/CIRCULATIONAHA.121.058777","article-title":"Hippo\u2013Yap signaling maintains sinoatrial node homeostasis","volume":"146","author":"Zheng","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0175","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","article-title":"Fibroblast GSK-3alpha promotes fibrosis via RAF\u2013MEK\u2013ERK pathway in the injured heart","volume":"131","author":"Umbarkar","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0180","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.123.066298","article-title":"Versican promotes cardiomyocyte proliferation and cardiac repair","volume":"149","author":"Feng","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.122.321050","article-title":"ATF4 protects the heart from failure by antagonizing oxidative stress","volume":"131","author":"Wang","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/CIRCULATIONAHA.124.070738","article-title":"Activation of imprinted gene PW1 promotes cardiac fibrosis after ischemic injury","volume":"151","author":"Kou","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.123.322596","article-title":"TGF-beta1\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post-myocardial infarction by inhibiting HDAC3","volume":"133","author":"Weng","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0200","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/CIRCULATIONAHA.121.056850","article-title":"lncExACT1 and DCHS2 regulate physiological and pathological cardiac growth","volume":"145","author":"Li","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0205","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.121.055841","article-title":"Elevated MCU expression by CaMKIIdeltaB limits pathological cardiac remodeling","volume":"145","author":"Wang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCULATIONAHA.123.066542","article-title":"Novel Pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function","volume":"149","author":"Xu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0215","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/eurheartj\/ehac042","article-title":"Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy","volume":"43","author":"Dawkins","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0220","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/CIRCULATIONAHA.121.057329","article-title":"Defective desmosomal adhesion causes arrhythmogenic cardiomyopathy by involving an integrin-alphaVbeta6\/TGF-beta signaling cascade","volume":"146","author":"Schinner","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0225","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/CIRCRESAHA.122.321725","article-title":"Targeting Wnt-\u03b2-catenin-FOSL signaling ameliorates right ventricular remodeling","volume":"132","author":"Nayakanti","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCRESAHA.121.320324","article-title":"p53 regulates the extent of fibroblast proliferation and fibrosis in left ventricle pressure overload","volume":"133","author":"Liu","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/d41573-024-00081-9","article-title":"Tackling the challenges of new approach methods for predicting drug effects from model systems","volume":"23","author":"Pang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.07.016_bb0240","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.124.070413","article-title":"ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity","volume":"151","author":"Mukherjee","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0250","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/CIRCRESAHA.124.324812","article-title":"Targeting cyclophilin A in the cardiac microenvironment preserves heart function and structure in failing hearts","volume":"135","author":"Sigle","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvad179","article-title":"'Trapped re-entry' as source of acute focal atrial arrhythmias","volume":"120","author":"De Coster","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1025430","article-title":"Artificial intelligence analysis of the impact of fibrosis in arrhythmogenesis and drug response","volume":"13","author":"Sanchez de la Nava","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0265","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","article-title":"Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction","volume":"147","author":"Tani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0270","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.123.324183","article-title":"Age-dependent RGS5 loss in pericytes induces cardiac dysfunction and fibrosis","volume":"134","author":"Tamiato","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0275","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1038\/s41467-024-52221-9","article-title":"Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.016_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114642","article-title":"Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38\/FOS\/MMP1-mediated inhibition of myocardial hypertrophy and fibrosis","volume":"162","author":"Fan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2025.07.016_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/science.adu9375","article-title":"Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization","volume":"388","author":"Abilez","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.016_bb0290","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCRESAHA.124.325212","article-title":"CAR-macrophage therapy alleviates myocardial ischemia\u2013reperfusion injury","volume":"135","author":"Wang","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0295","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","article-title":"Alox15\/15-HpETE aggravates myocardial ischemia\u2013reperfusion injury by promoting cardiomyocyte ferroptosis","volume":"147","author":"Cai","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0300","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.016_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115837","article-title":"Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR\/Myd88\/TRAF\/NF-kappaB and p38MAPK\/CREB signaling pathways","volume":"168","author":"Dawuti","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2025.07.016_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274618","article-title":"Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction","volume":"17","author":"Ma","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2025.07.016_bb0315","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/thno.97767","article-title":"Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction","volume":"14","author":"Yuan","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.tips.2025.07.016_bb0320","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/eurheartj\/ehad114","article-title":"Intrapericardial long non-coding RNA-Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair","volume":"44","author":"Zhu","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.123.065874","article-title":"Frequent premature atrial contractions lead to adverse atrial remodeling and atrial fibrillation in a swine model","volume":"149","author":"Higuchi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0330","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41551-023-01134-x","article-title":"Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction","volume":"8","author":"Tu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tips.2025.07.016_bb0335","article-title":"Imaging characterization of myocardial function, fibrosis, and perfusion in a nonhuman primate model with heart failure-like features","volume":"10","author":"Liu","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114365","article-title":"Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes","volume":"160","author":"Mel\u00e9ndez","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2025.07.016_bb0345","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1111\/jcmm.17478","article-title":"Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-beta1\/Smad3 signalling pathway","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0350","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvy186","article-title":"Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension","volume":"115","author":"Rol","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0355","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.3390\/ijms24108998","article-title":"Single-dose treatment with rapamycin preserves post-ischemic cardiac function through attenuation of fibrosis and inflammation in diabetic rabbit","volume":"24","author":"Samidurai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2025.07.016_bb0360","doi-asserted-by":"crossref","first-page":"30764","DOI":"10.1038\/s41598-024-80829-w","article-title":"Effects of empagliflozin and dapagliflozin in alleviating cardiac fibrosis through sirt6-mediated oxidative stress reduction","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2025.07.016_bb0365","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and cilinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2025.07.016_bb0370","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41573-025-01158-9","article-title":"Fibrosis: cross-organ biology and pathways to development of innovative drugs","volume":"24","author":"Rieder","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.07.016_bb0375","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.016_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114884","article-title":"Relaxin as an anti-fibrotic treatment: perspectives, challenges and future directions","volume":"197","author":"Samuel","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.016_bb0385","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034067","article-title":"Novel relaxin receptor RXFP1 agonist AZD3427 in the treatment of heart failure: a Phase 1a\/b, first-in-human, randomized, single-blind, placebo-controlled study","volume":"13","author":"Connolly","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.tips.2025.07.016_bb0390","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1021\/acs.jmedchem.3c02184","article-title":"Discovery of clinical candidate AZD5462, a selective oral allosteric RXFP1 agonist for treatment of heart failure","volume":"67","author":"Granberg","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.07.016_bb0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","article-title":"Colchicine in cardiovascular disease: in-depth review","volume":"145","author":"Deftereos","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0400","article-title":"Colchicine therapy in cardiovascular medicine: a literature review","volume":"52","author":"Trube","year":"2025","journal-title":"Am. Heart J. Plus"},{"key":"10.1016\/j.tips.2025.07.016_bb0405","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024668","article-title":"Characteristics associated with growth differentiation factor 15 in heart failure with preserved ejection fraction and the impact of pirfenidone","volume":"11","author":"Lewis","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.tips.2025.07.016_bb0410","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10741-021-10175-w","article-title":"Pirfenidone as a novel cardiac protective treatment","volume":"27","author":"Aimo","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.tips.2025.07.016_bb0415","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cardfail.2023.02.010","article-title":"Treatment adherence in a randomized controlled trial of pirfenidone in HFpEF: determinants and impact on efficacy","volume":"29","author":"Soltani","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.tips.2025.07.016_bb0420","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0425","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12872-024-04103-7","article-title":"Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis","volume":"24","author":"Elshahat","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.tips.2025.07.016_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102615","article-title":"Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials","volume":"49","author":"Pamporis","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0435","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011629","article-title":"Mineralocorticoid receptor antagonists in heart failure: an update","volume":"17","author":"Ferreira","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.tips.2025.07.016_bb0440","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/ph18030313","article-title":"Cardiac fibrosis: mechanistic discoveries linked to SGLT2 inhibitors","volume":"18","author":"Rolski","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2025.07.016_bb0445","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11033-025-10260-5","article-title":"Empagliflozin in diabetic cardiomyopathy: elucidating mechanisms, therapeutic potentials, and future directions","volume":"52","author":"Jaiswal","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tips.2025.07.016_bb0450","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s40265-022-01778-0","article-title":"Empagliflozin: a review in symptomatic chronic heart failure","volume":"82","author":"Frampton","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2025.07.016_bb0455","article-title":"Dapagliflozin's role in heart failure: an overview of clinical trial evidence","volume":"16","author":"Khan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.tips.2025.07.016_bb0460","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.3390\/jcm12216798","article-title":"Current role of SLGT2 inhibitors in the management of the whole spectrum of heart failure: focus on dapagliflozin","volume":"12","author":"Escobar","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-087617","article-title":"Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial","volume":"14","author":"Yan","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.tips.2025.07.016_bb0470","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.tips.2025.07.016_bb0475","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis \u2013 a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tips.2025.07.016_bb0480","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","article-title":"Cardiovascular protection using beta-blockers: a critical review of the evidence","volume":"50","author":"Bangalore","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0485","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3390\/jcm14041347","article-title":"Efficacy of dolchicine in reducing NT-proBNP, caspase-1, TGF-beta, and galectin-3 expression and improving echocardiography parameters in acute myocardial infarction: a multi-center, randomized, placebo-controlled, double-blinded clinical trial","volume":"14","author":"Astiawati","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0490","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1093\/eurheartj\/ehae538","article-title":"Colchicine in acutely decompensated heart failure: the COLICA trial","volume":"45","author":"Pascual-Figal","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0495","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/aor.14503","article-title":"FDA Modernization Act 2.0 allows for alternatives to animal testing","volume":"47","author":"Han","year":"2023","journal-title":"Artif. Organs"},{"key":"10.1016\/j.tips.2025.07.016_bb0500","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2016.01.083","article-title":"Translation of human-induced pluripotent stem cells: from clinical trial in a dish to precision medicine","volume":"67","author":"Sayed","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0505","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175824","article-title":"FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2025.07.016_bb0510","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1093\/eurheartj\/ehae519","article-title":"Clinical trials in-a-dish for cardiovascular medicine","volume":"45","author":"Wu","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0515","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/ATVBAHA.120.314695","article-title":"Clinical trial in a dish: using patient-derived induced pluripotent stem cells to identify risks of drug-induced cardiotoxicity","volume":"41","author":"Lam","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2025.07.016_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9276","article-title":"Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy","volume":"12","author":"Sayed","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2025.07.016_bb0525","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2025.07.016_bb0530","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.016_bb0535","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/cells9020451","article-title":"The crosstalk between cardiac lipotoxicity and mitochondrial oxidative stress in the cardiac alterations in diet-induced obesity in rats","volume":"9","author":"Jimenez-Gonzalez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tips.2025.07.016_bb0540","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tips.2025.07.016_bb0545","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/resp.12815","article-title":"Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways","volume":"21","author":"Chen","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.tips.2025.07.016_bb0550","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1093\/cvr\/cvad140","article-title":"Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease","volume":"119","author":"Kattih","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0555","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jcmg.2020.11.006","article-title":"Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes","volume":"14","author":"Mandawat","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.tips.2025.07.016_bb0560","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/cvr\/cvab206","article-title":"Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure","volume":"118","author":"Jackson","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0565","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/eurheartj\/ehad115","article-title":"Proteomic cardiovascular risk assessment in chronic kidney disease","volume":"44","author":"Deo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2025.07.016_bb0570","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.123.067620","article-title":"Mineralocorticoid receptor antagonism prevents aortic plaque progression and reduces left ventricular mass and fibrosis in patients with type 2 diabetes and chronic kidney disease: the MAGMA trial","volume":"150","author":"Rajagopalan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2025.07.016_bb0575","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/cvr\/cvab161","article-title":"Senescence mechanisms and targets in the heart","volume":"118","author":"Chen","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0580","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/cells11081316","article-title":"CVD and COVID-19: emerging roles of cardiac fibroblasts and myofibroblasts","volume":"11","author":"Katwa","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tips.2025.07.016_bb0585","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.123.323346","article-title":"Exercise inhibits doxorubicin-induced cardiotoxicity via regulating B cells","volume":"134","author":"Wang","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2025.07.016_bb0590","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41569-024-01056-4","article-title":"Consequences of ionizing radiation exposure to the cardiovascular system","volume":"21","author":"Jahng","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2025.07.016_bb0595","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41569-025-01121-6","article-title":"The relationship between cannabis and cardiovascular disease: clearing the haze","volume":"22","author":"Chandy","year":"2025","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:52:07Z","timestamp":1772815927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":119,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0165614725001592"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.07.016","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac fibrosis: from mechanisms and models to medicines","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}